The global Pharmaceutical Analytical Testing Outsourcing Market size is expected to reach USD 14.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2022 to 2030. Increasing biological candidate pipelines, rising demand for additional analytical details on drugs, and process development by regulatory agencies are driving the market growth. Analytical testing aids in real-time product quality control as well as helps optimize and monitor processes, thereby identifying different drugs. Over the years, the number of clinical trials has increased consistently.
For instance, in 2021, over 399,525
clinical studies were registered on ClinicalTrial.gov, whereas as of June 2022,
it had increased to over 421,258 studies. A continuation of this trend is
expected to have a positive impact on the market in the post-pandemic period.
The majority of small and medium-sized pharma companies lack the infrastructure
for analytical testing. As a result, outsourcing these operations is the best
option as it saves time and money. The patent cliff, primarily for small
molecules and biologics, is likely to have a positive impact on the market as
it will increase the number of commercial drugs in the pharma market, thus
promoting the analytical testing of commercially available generic drugs.
There has been a rise in several diseases
post-COVID-19. For instance, according to a report published by Children’s
National Hospital- pediatric research and clinical innovations center, a study
was performed on 737 youths who were diagnosed with diabetes, and it found an
increased incidence of pediatric Type 1 Diabetes (T1D) by 15.2% and Type 2 Diabetes
(T2D) increased by 182% between March 11, 2018, and March 10, 2021. The rise in
disease incidence is expected to improve, drug production, which is likely to
drive the demand for analytical services for commercial drugs.
Related Press Release@ Pharmaceutical
Analytical Testing Outsourcing Market Report
Pharmaceutical
Analytical Testing Outsourcing Market Report Highlights
- The bioanalytical testing segment is expected to
witness the fastest CAGR of 8.9% over the forecast due to the high number
of clinical trial registrations and entry of new drug participants into
the pharmaceutical market
- The pharmaceutical segment gained the largest
revenue share of 47.4% in 2021. The growing demand among pharmaceutical
companies to focus on their core competencies is one of the major reasons
for the largest segment share
- North America is expected to hold the largest
revenue share of 53.7% owing to the presence of a significant number of
pharmaceutical companies in the region
- Asia Pacific is anticipated to be the
fastest-growing regional market from 2022 to 2030 due to the low-cost
service offerings by the third-party service providers in the region
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment